newsfilter
← Latest News
Business Wire·

Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period

Regencell Bioscience Holdings Limited (NASDAQ:RGC): Results of EARTH efficacy trial EARTH Efficacy Trials Period of trial 30 January 2022 –31 March 2022(EARTH-B Trial) 1 October 2021 –31 January 2022(EARTH-A Tri